Loading [MathJax]/extensions/mml2jax.js
Skip to main content
Library homepage
 

Text Color

Text Size

 

Margin Size

 

Font Type

Enable Dyslexic Font
Biology LibreTexts

Search

  • Filter Results
  • Location
  • Classification
    • Article type
    • Author
    • Embed NoteBene
    • Cover Page
    • License
    • Show TOC
    • Transcluded
    • Annotation System
    • Number of Print Columns
    • PrintOptions
    • Print CSS
    • OER program or Publisher
    • Autonumber Section Headings
    • License Version
  • Include attachments
Searching in
About 1 results
  • https://bio.libretexts.org/Courses/City_College_of_San_Francisco/Introduction_to_Genetics/13%3A_Cancer_Genetics/13.07%3A__The_Poster_Boy_of_Genetic_Research_Leading_to_a_Cancer_Treatment__Gleevec_(Imatinib)
    This page discusses chronic myelogenous leukemia (CML), a blood cancer caused by the BCR-ABL chimeric protein leading to unchecked myeloid cell growth. The targeted therapy Gleevec™ (imatinib) inhibit...This page discusses chronic myelogenous leukemia (CML), a blood cancer caused by the BCR-ABL chimeric protein leading to unchecked myeloid cell growth. The targeted therapy Gleevec™ (imatinib) inhibits this protein's kinase activity, effectively managing the disease but not curing it. Treatment challenges arise from patient variability and potential drug resistance, complicating effective management of CML.

Support Center

How can we help?